Haemophilia A is an inherited bleeding disorder where a person’s blood does not clot properly due to a lack or insufficient levels of a blood clotting protein known as factor VIII. Roche is developing novel approaches to hopefully advance the management of this serious disorder.
Dr Gallia Levy, Associate Group Medical Director at Roche, shares her perspective on the need for sustained bleeding protection in haemophilia A.
mehrRoche's Chief Medical Officer Sandra Horning discusses Roche's experience with monoclonal antibodies, and how this technology could be used for the treatment of haemophilia A.
The formation of a blood clot is an important process that stops a person from bleeding. Meet "Team Clotting" and learn more about how the clotting cascade works by watching these interactive videos.
The haemophilia community is united and strong. Find out more about the haemophilia community and progress being made in the field from Brian O’Mahony, Chief Executive of the Irish Haemophilia Society.
mehrMichael and Mirko share their different perspectives on living with haemophilia A.
Learn about some of the key milestones in the development and engineering of monoclonal antibodies, and the role they play in medicine, in this animated video.
